Figure 2

RT-qPCR analysis of new circulating miRNAs. (A) Quantification of the levels of miRNA in serum/plasma samples from FJD and HVH patients. After the Shapiro‒Wilk normality test, two-way ANOVA tests were applied (*p<0.05, **p<0.01, ***p<0.001, ****p<0.0001). (B) Plot of HC, ICD, and MCC individuals considering miR-Contig-1519 and miR-Contig-3244 data.